MRK Competitors & Alternatives
Compare Merck & Company Inc with similar stocks in the same industry
Drug Manufacturers - General
MRK
Main Stock$147.76
Tradestie Score
53
Market Cap
$225.13B
P/E Ratio
148.4
Revenue Growth
0.0%
Analyst Upside
+9.3%
Top Competitors
18 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JNJ
Johnson & Johnson
|
$285.75
|
$448.07B | 43.0 | 53 | Compare |
|
ABBV
ABBVIE INC.
|
$295.03
|
$431.71B | 50.6 | 49 | Compare |
|
PG
Procter & Gamble Company
|
$169.80
|
$358.52B | 25.3 | 25 | Compare |
|
NVO
Novo-Nordisk A/S
|
$41.63
|
$262.92B | 10.4 | 45 | Compare |
|
AZN
AstraZeneca PLC
|
$184.45
|
$261.56B | 26.1 | 37 | Compare |
|
NVS
Novartis AG
|
$160.50
|
$254.99B | 30.6 | 36 | Compare |
|
VZ
Verizon Communications
|
$46.36
|
$184.80B | 11.9 | 50 | Compare |
|
AMGN
Amgen Inc
|
$465.67
|
$160.70B | 27.1 | 39 | Compare |
|
PFE
Pfizer Inc.
|
$28.89
|
$154.70B | 41.2 | 49 | Compare |
|
GILD
Gilead Sciences Inc
|
$168.08
|
$137.92B | - | 47 | Compare |
More MRK Analysis
Data updated: Nov 15, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
18 stocks in this industry